CXCL8 and rheumatoid arthritis: Neutrophil membrane coating endowed this carrier with the ability to target the inflamed synovial tissue and enter the synovial fluid via the chemotactic functions of IL-8, which is present at high levels in synovial fluid from patients with RA.